Anti-Insulin Receptor beta 抗体 [C18C4] (ab69508)

ab69508 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab69508 は 7 報の論文で使用されています。

  • Zhao W  et al. Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-? and insulin receptor in a rat model of nonalcoholic fatty liver disease. Exp Ther Med 11:183-190 (2016). PubMed: 26889237
  • Leonard S  et al. Regulating the effects of GPR21, a novel target for type 2 diabetes. Sci Rep 6:27002 (2016). WB . PubMed: 27243589
  • Yamaguchi T  et al. ROR1 sustains caveolae and survival signalling as a scaffold of cavin-1 and caveolin-1. Nat Commun 7:10060 (2016). PubMed: 26725982
  • Wairagu PM  et al. Insulin priming effect on estradiol-induced breast cancer metabolism and growth. Cancer Biol Ther 16:484-92 (2015). WB ; Human . PubMed: 25701261
  • Wu C  et al. RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer. Nat Commun 5:3149 (2014). Human . PubMed: 24476626
  • Drapeau N  et al. Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes. Am J Physiol Endocrinol Metab 304:E1188-98 (2013). PubMed: 23531619
  • Guo T  et al. Characterization of the gene expression profile of heterozygous liver-specific glucokinase knockout mice at a young age. Biomed Pharmacother 66:587-96 (2012). PubMed: 23085254

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録